Irebesartan products under recall

• the introduction of 15 new indicators (worth 101 points) to bring QOF into closer alignment with NICE guidance and Screening Committee recommendations, mainly on diabetes, blood pressure control and cervical screening. The rationale and changes to requirements are detailed in the appropriate clinical domain in Sections 3 and 4 of this document. ................
................